|
1）Bucala R, Spiegel LA, Chesney J, et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med. 1994; 1: 71-81
|
|
|
|
2）Stirling GA, Kakkar VV. Cells in the circulating blood capable of producing connective tissue. Br J exp Path. 1969; 50: 51-5
|
|
|
|
|
|
3）Krstic RV. Ultrastructure of the mammalian cell. An Atlas. Springer-Verlag; 1979. p. 76-7
|
|
|
|
|
|
4）Abe R, Donnelly SC, Peng T, et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol. 2001; 166: 7556-62
|
|
|
|
|
|
5）Hong KM, Belperio JA, Keane MP, et al. Differentiation of human circulating fibrocytes as mediated by transforming growth factor-β and peroxisome proliferator-activated receptor γ. J Biol Chem. 2007; 282: 22910-20
|
|
|
|
|
6）Ishii G, Sangai T, Sugiyama K, et al. In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. Stem Cells. 2005; 23: 699-706
|
|
|
|
|
|
7）Fathke C, Wilson L, Hutter J, et al. Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells. 2004; 22: 812-22
|
|
|
|
|
|
8）Higashiyama R, Nakao S, Shibusawa Y, et al. Differential contribution of dermal resident and bone marrow-derived cells to collagen production during wound healing and fibrogenesis in mice. J Invest Dermatol. 2011; 131: 529-36
|
|
|
|
|
|
9）Chesney J, Metz C, Stavisky AB, et al. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol. 1998; 160: 419-25
|
|
|
|
|
|
10）Quan TE, Cowper S, Wu SP, et al. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol. 2004; 36: 598-606
|
|
|
|
|
|
11）Wang JF, Jiao H, Stewart TL, et al. Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Rep Reg. 2007; 15: 113-21
|
|
|
|
|
|
12）Chesney J, Bacher M, Bender A, et al. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A. 1997; 94: 6307-12
|
|
|
|
|
|
13）Hashimoto N, Jin H, Liu T, et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest. 2004; 113: 243-52
|
|
|
|
|
|
14）Phillips RJ, Burdick MD, Hong K, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediates fibrosis. J Clin Invest. 2004; 114: 438-46
|
|
|
|
|
|
15）Moore BB, Murray L, Das A, et al. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol. 2006; 35: 175-81
|
|
|
|
|
|
16）Moore BB, Kolodsick JE, Thannickal VJ, et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol. 2005; 166: 675-84
|
|
|
|
|
|
17）Ishida Y, Kimura A, Kondo T, et al. Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmolnary fibrosis through regulation of macrohpgaes and fibrocyte infiltration. Am J Pathol. 2007; 170: 843-54
|
|
|
|
|
|
18） Sakai N, Wada T, Yokoyama H, et al. Secondary lymphoid tissue chemokine （SLC/CCL21）/CCR7 signaling regulates fibrocytes in renalfibrosis. Proc Natl Acad Sci U S A. 2006; 103: 14098-103
|
|
|
|
|
|
19）Tanjore H, Xu XC, Polosukhin VV, et al. Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med. 2009; 180: 657-65
|
|
|
|
|
|
20）Reilkoff RA, Bucala R, Herzog E. Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol. 2011; 11: 427-35
|
|
|
|
|
|
21）Abe S, Okazaki H, Kishi M, et al. Fibrocytes regulates lung fibroblast activation. Am J Respir Crit Care Med. 2012; 185: A4460
|
|
|
|
|
|
22）Mehrad B, Burdick MD, Zisman DA, et al. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Com. 2007; 353: 104-8
|
|
|
|
|
|
23）Andersson-Sjoland A, de Alba CG, Nihlberg K, et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol. 2008; 40: 2129-40
|
|
|
|
|
|
24） Moeller A, Gilpin SE, Ask K, et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009; 179: 588-94
|
|
|
|
|
|
25）Fujiwara A, Kobayashi H, Masuya M, et al. Correlation between circulating fibrocytes, and activity and progression of interstitial lung diseases. Respirology. 2012; 17: 693-8
|
|
|
|
|
|
26）Pilling D, Roife D, Wang M, et al. Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J Immunol. 2007; 179: 4035-44
|
|
|
|
|